Archive
New particle could form the basis of energy-saving electronics
The Weyl fermion, just discovered in the past year, moves through materials practically without resistance. Now researchers are showing how it could be put to use in electronic components.
From the Higgs boson to new drugs
A picture-perfect example of how basic research makes concrete contributions to the economy is the company DECTRIS — a PSI spin-off founded in 2006 and already highly successful. The latest development from DECTRIS is a detector called EIGER, which is used for X-ray measurements at large research facilities. There EIGER contributes, among other things, to the search for new drugs.
Five hundred thousand times less likely than winning the lottery
Measuring the rarity of a particle decayIn the so-called MEG experiment at the PSI, researchers are searching for an extremely rare decay signature from a certain kind of elementary particles known as muons. More precisely, they are quantifying its improbability. According to their latest number, this decay occurs less than once in 2.4 trillion events. By means of this result, theoretical physicists can sort out which of their approaches to describing the universe will hold up against reality.
Medicines made to order with pinpoint precision
At PSI, scientists are developing new medicines against cancer. These contain radioactive substances that can be injected into the patients and thus make their way to the tumour. There, in direct contact, their radiation should destroy the cancer cells. Before such a radioactive medicine can be tested on patients in the first clinical trials, however, its safety must be guaranteed to ensure that the patient will not be harmed. Therefore every agent is produced at the PSI under sterile conditions and tested – separately for each patient, and only on the doctor's order.